Explore Stanford technologies available for licensing:

SARS-CoV2 is known to gain entry into epithelial cells through the association of its viral spike protein with the ACE2 receptor, which is widely expressed on epithelial cell types.

Stanford researchers developed an electrochemical reactor process that combines electrodialysis and membrane stripping, reduces the chemical inputs needed and expands recovered product portfolio to alkaline ammonia (for cleaning products) in ratios customized to a user's speci

Stanford researchers have developed an Electrodialysis and Nitrate Reduction Process (EDNR) that produces high-purity ammonia from agricultural runoff.

Stanford researchers have developed an "electrocatalyst-in-a-box" that extracts wastewater nitrate and converts it into ammonia. Nitrogen pollution threatens water security and human health, and demand for ammonia continues to grow.

Stanford researchers have engineered a heterologous system for the high-efficiency production of numerous taxanes and taxane intermediates.

Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases, making it the leading cause of cancer-related deaths globally. Post-surgical recurrence and treatment resistance are the main causes of cancer-related mortality.

Stanford researchers have developed a more sensitive and accurate pathogenic infection diagnosis method using intact genetically modified pathogens. Pathogen infection clinical diagnosis requires direct pathogen detection or the detection of pathogen specific antibodies.

Researchers at Stanford have developed a fast and accurate algorithm for analyzing heartbeat patterns in real time.

Wireless spectrum is increasingly fragmented due to the growing proliferation of unlicensed wireless devices and piecemeal licensed spectrum allocations.

Stanford researchers have developed a first-in-class, non-hormonal male contraceptive that works by targeting a protein found only in developing sperm cells.

Stanford researchers have developed a proteomic biomarker-based algorithm for efficiently diagnosing circadian rhythm and sleep disorders.

Trogocytosis is a phenomenon in which one cell transfers small, membrane-bound vesicles called trogocytotic vesicles to another cell.

Stanford researchers have developed an oral formula and method to reduce the risk of developing food allergies. This patented formula can reduce the risk of food allergy in different age groups when given as part of a normal daily diet.

Stanford researchers have developed a modular system of Synthetic cytokine receptors (SCRs), which are customizable receptors that mimic cytokine signals to precisely control immune cell behavior without the need for external cytokines.

Researchers at Stanford University have demonstrated rapid and accurate identification of extracellular vesicles (EVs) from different cell lines using an AI-assisted optical platform.